Stock Analysis

Taiflex Scientific Third Quarter 2024 Earnings: Misses Expectations

Published
TWSE:8039

Taiflex Scientific (TWSE:8039) Third Quarter 2024 Results

Key Financial Results

  • Revenue: NT$2.85b (up 15% from 3Q 2023).
  • Net income: NT$159.3m (down 42% from 3Q 2023).
  • Profit margin: 5.6% (down from 11% in 3Q 2023). The decrease in margin was driven by higher expenses.
  • EPS: NT$0.65 (down from NT$1.26 in 3Q 2023).
TWSE:8039 Earnings and Revenue History November 4th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Taiflex Scientific Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 10%. Earnings per share (EPS) also missed analyst estimates by 58%.

The company's shares are down 6.2% from a week ago.

Risk Analysis

Be aware that Taiflex Scientific is showing 3 warning signs in our investment analysis and 1 of those makes us a bit uncomfortable...

Valuation is complex, but we're here to simplify it.

Discover if Taiflex Scientific might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.